Compare PharmaCielo (PCLOF) With Other Cannabis Stocks

Head-to-head stock comparisons across price, valuation, financials, and growth metrics

Company

PharmaCielo (PCLOF)

Price

$0.04

Change

-26.40%

Market Cap

$7.4M

Sector

CBD

CBD Sector Peers

All CBD cannabis companies sorted by market capitalization. Click any ticker to see a detailed head-to-head comparison.

TickerNamePriceChange %MCap
CWBHFCharlotte's Web Holdings$0.62-0.22%$99.3M
PKANFSimply Better Brands$0.210.00%$22.2M
YCBDcbdMD Inc$0.71-0.75%$7.5M
OILFFNextleaf Solutions$0.04+1.93%$7.1M
CVSICV Sciences$0.04-12.42%$6.5M
DHBUFDelivra Health Brands$0.14+10.51%$4.4M
ELLXFElixinol Global$0.010.00%$1.9M
CBDNFCBD Global Sciences$0.04+16.39%$1.8M
GBHPFGlobal Hemp Group$0.010.00%$178.0K
CNTRFCentr Brands$0.010.00%$139.2K

Top Matchups by Market Cap

Companies closest to PharmaCielo in market capitalization — the most meaningful head-to-head comparisons.

YCBDCBD

cbdMD Inc

MCap: $7.5M

$0.71-0.75%
Compare
OILFFCBD

Nextleaf Solutions

MCap: $7.1M

$0.04+1.93%
Compare
WEEDETF

Roundhill Cannabis ETF

MCap: $7.8M

$16.36+0.15%
Compare
UNRVMSO

Unrivaled Brands

MCap: $8.3M

$0.750.00%
Compare
CVSICBD

CV Sciences

MCap: $6.5M

$0.04-12.42%
Compare

Cross-Sector Comparisons

Top cannabis companies outside the CBD sector. Compare across different business models and market segments.

JAZZBiotech

Jazz Pharmaceuticals

MCap: $10.99B

$178.55-1.66%
Compare
SMGAncillary

Scotts Miracle-Gro

MCap: $3.54B

$60.96+0.96%
Compare
CURLFMSO

Curaleaf Holdings

MCap: $1.80B

$2.36+2.83%
Compare
TPBAncillary

Turning Point Brands

MCap: $1.73B

$90.62+0.69%
Compare
GTBIFMSO

Green Thumb Industries

MCap: $1.54B

$6.56+7.01%
Compare

Comparing PCLOF in the Cannabis Market

PharmaCielo (PCLOF) is a CBD-sector cannabis company trading at $0.04 per share with a market capitalization of $7.4M. Among its CBD peers, PCLOF ranks #4 by market cap, with trailing twelve-month revenue of $0 and a gross margin of 0.0%. The stock has moved -26.40% in the current session, trading on the OTC exchange.

When comparing PCLOF against other cannabis stocks, investors should consider key financial metrics including price-to-sales ratio (N/A), revenue growth (0.00% YoY), and balance sheet strength (cash of $0 vs. debt of $0). The comparison tables above allow you to evaluate PharmaCielo relative to 10 sector peers and leading companies across all cannabis sub-sectors, helping you identify which stocks offer better value, stronger growth, or more favorable risk profiles.

Frequently Asked Questions

How does PCLOF compare to other CBD stocks?+
PharmaCielo has a market cap of $7.4M, placing it among 11 companies in the CBD sector. Its price-to-sales ratio is N/A and its gross margin is 0.0%. Use the table above to compare these metrics against every CBD peer.
What is PCLOF's biggest competitor?+
By market capitalization, the closest comparable company is cbdMD Inc (YCBD) with a market cap of $7.5M. Click the compare link to view a full head-to-head analysis.
Is PCLOF overvalued compared to its peers?+
PharmaCielo trades at a P/S ratio of N/A. Compare this to sector peers in the table above to determine relative valuation. A lower P/S may indicate relative value, while a higher P/S may reflect growth expectations.
Which cannabis stock has better margins than PCLOF?+
PharmaCielo has a gross margin of 0.0%. Among its CBD peers, 1 companies report higher gross margins. See the Sector Peers table for a full ranking.
Can I compare PCLOF to stocks in other cannabis sectors?+
Yes. The Cross-Sector Comparisons section above features top companies from sectors outside CBD. You can click any company to see a full side-by-side comparison with PCLOF covering price, valuation, financials, and growth metrics.

Related Pages

Disclaimer: The comparison data on this page is for informational purposes only and does not constitute financial advice, investment recommendations, or an endorsement of any security. Cannabis stocks are highly volatile and subject to unique regulatory risks. Always conduct your own research and consult a licensed financial advisor before making investment decisions.Cannabismarketcap does not guarantee the accuracy or completeness of any data presented.